Angiodynamics (ANGO) Restructuring Costs (2012 - 2026)

Angiodynamics (ANGO) has reported Restructuring Costs for 15 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Restructuring Costs rose 117.31% year-over-year to $4.7 million; the trailing twelve-month figure through May 2026 stood at $17.6 million (up 12.66% YoY), and the FY2026 full-year result was $17.6 million, up 12.66% from the prior year.
• Restructuring Costs retreated to $4.7 million in Q2 2026 per ANGO's latest filing, from $6.5 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $35.4 million in Q1 2024 and bottomed at $2.0 million in Q2 2022.
• Historically, Restructuring Costs has averaged $5.9 million across 5 years, with a median of $3.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs soared 949.78% in 2024, then slumped 90.71% in 2025.
• Over 5 years, Restructuring Costs stood at $3.1 million in 2022, then jumped by 102.29% to $6.2 million in 2023, then dropped by 5.17% to $5.9 million in 2024, then plunged by 38.05% to $3.6 million in 2025, then grew by 28.83% to $4.7 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $4.7 million, $6.5 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.